Fifteen researchers from the Radboud University and Radboud university medical center have been awarded a Veni grant by NWO, the Netherlands Organisation for Scientific Research. These grants of up to €250,000 provide highly promising young scientists with the opportunity to further elaborate their own ideas during a period of three years.Frans Bianchi, theme Cancer development and immune defense received a Veni grant with his project: "Cell surface proteins: an overlooked source of antigens".
Diseased cells present pieces of proteins (epitopes) on their surface, allowing their recognition and elimination by the immune system. Many epitopes are generated by unknown mechanisms from membrane-proteins. Using chemical fluorescent reporters, Frans Bianchi will investigate how these are presented.
15 Veni grants for Radboud researchers: more information in this link.
Related news items
Connecting splicing and epigenetics in skin stem-cells20 November 2018
Sabine Tanis and Klaas Mulder, theme Cancer develoment and immune defense, found that part of this robustness is conferred by functional connections between transcriptional/epigenetic and splicing regulation of genes involved in cell-cell contacts. Their findings are published in Cell reports.read more
Cancer cell moves like a predator Lévy walk may be the weak spot of cancer cells19 November 2018
In contrast to their non-metastatic counterparts, metastatic cancer cells show movement patterns that are also often employed by predators searching for prey. This was shown by an international study on movement patterns of cancer cells published in Nature Communicationsread more
VSB Scholarships for studying or doing research abroad16 November 2018
For those of you who have supervised or will supervise students who finish their BSc or MSc between 1-3-2018 and 31-12-2019.read more
Sepsis-associated acute kidney injury: A randomized clinical trial15 November 2018
Peter Pickkers, theme Infectious diseases and global health, published in JAMA, that among patients who were critically ill with sepsis-associated acute kidney injury, human recombinant alkaline phosphatase compared with placebo did not significantly improve short-term kidney function.read more